162 related articles for article (PubMed ID: 37373229)
1. D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study.
Porcaro G; Bilotta G; Capoccia E; Bezerra Espinola MS; Aragona C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373229
[TBL] [Abstract][Full Text] [Related]
2. Unopposed estrogens: current and future perspectives.
Montanino Oliva M; Gambioli R; Forte G; Porcaro G; Aragona C; Unfer V
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2975-2989. PubMed ID: 35503642
[TBL] [Abstract][Full Text] [Related]
3. The use of D-chiro-Inositol in clinical practice.
Gambioli R; Forte G; Aragona C; Bevilacqua A; Bizzarri M; Unfer V
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):438-446. PubMed ID: 33506934
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract][Full Text] [Related]
5. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
[TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
Haoula ZJ; Walker KF; Powell MC
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152
[TBL] [Abstract][Full Text] [Related]
7. Letrozole as primary therapy for endometrial hyperplasia in young women.
Li HZ; Chen XN; Qiao J
Int J Gynaecol Obstet; 2008 Jan; 100(1):10-2. PubMed ID: 17889878
[TBL] [Abstract][Full Text] [Related]
8. Histological Pattern Of Endometrial Samples In Postmenopausal Women With Abnormal Uterine Bleeding.
Deeba F; Shaista ; Khan B
J Ayub Med Coll Abbottabad; 2016; 28(4):721-724. PubMed ID: 28586596
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
[TBL] [Abstract][Full Text] [Related]
10. Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence of hyperplasia during unopposed oestrogen use.
Meuwissen JH; Oddens BJ; Klinkhamer PJ
Maturitas; 1996 May; 24(1-2):21-30. PubMed ID: 8794430
[TBL] [Abstract][Full Text] [Related]
11. D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study.
Monastra G; Vazquez-Levin M; Bezerra Espinola MS; Bilotta G; Laganà AS; Unfer V
Basic Clin Androl; 2021 Jun; 31(1):13. PubMed ID: 34078260
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome.
Cheung AP
Obstet Gynecol; 2001 Aug; 98(2):325-31. PubMed ID: 11506853
[TBL] [Abstract][Full Text] [Related]
13. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
[TBL] [Abstract][Full Text] [Related]
14. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
17. Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
Girbash EF; Sherif HE; Radwan AM; Abdeldayem HM
Arch Gynecol Obstet; 2023 Sep; 308(3):947-952. PubMed ID: 37010614
[TBL] [Abstract][Full Text] [Related]
18. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
19. Could body mass index be an indicator for endometrial biopsy in premenopausal women with heavy menstrual bleeding?
Guraslan H; Dogan K; Kaya C; Senturk MB; Guraslan B; Helvacioglu C; Akbayir O; Yasar L
Arch Gynecol Obstet; 2016 Aug; 294(2):395-402. PubMed ID: 26895636
[TBL] [Abstract][Full Text] [Related]
20. THE STATE OF REPRODUCTIVE HEALTH OF WOMEN WITH HYPERPROLIFERATIVE PATHOLOGY OF THE ENDOMETRIUM.
Nikitina IM; Horban NY; Mykytyn KV; Kondratiuk KO; Smiian SA; Kalashnyk NV; Gerevich NV
Wiad Lek; 2021; 74(9 cz 1):2076-2081. PubMed ID: 34725279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
